REGEN BIOPHARMA, INC.

RGBPP ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2025

Total Assets: $274.6K

Liabilities Breakdown FY2025

Total Liabilities: $6.6M